National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

indicine-N-oxide
A natural pyrrolizidine alkaloid with antineoplastic properties. Indicine-N-oxide alkylates and crosslinks DNA. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:INDI
Chemical structure names:
  • 2,3-dihydroxy-2-(1-methylethyl)butanoic Acid (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester N-oxide
  • butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)- (2,3,5, 7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl) methyl ester, N-oxide,(1R-(1.alpha.,7(2R*,3S*),7a.beta))-(9CI)



Previous:inalimarev, Inapsine, Incel, incomplete Freund's adjuvant, indibulin
Next:indinavir sulfate, indium I 111 bevacizumab, indium I 111 chimeric monoclonal antibody G250, indium In 111 chimeric monoclonal antibody 806, indium In 111 CHX-A DTPA trastuzumab

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov